INVESTORS’ RIGHTS AGREEMENT BY AND BETWEEN ACTINIUM PHARMACEUTICALS, INC. AND MEMORIAL SLOAN KETTERING CANCER CENTERInvestors’ Rights Agreement • December 23rd, 2015 • Memorial Sloan-Kettering Cancer Center • Pharmaceutical preparations • New York
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 21st day of December, 2015, by and between Actinium Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Memorial Sloan Kettering Cancer Center, a New York not-for-profit corporation (“MSKCC”).
JOINT FILING AGREEMENTJoint Filing Agreement • January 18th, 2013 • Memorial Sloan-Kettering Cancer Center • Blank checks
The undersigned hereby agree that the Schedule 13D with respect to the Common Stock of Cactus Ventures, Inc., dated as of January 18, 2013, is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(f) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • August 23rd, 2013 • Memorial Sloan-Kettering Cancer Center • Blank checks
The undersigned hereby agree that the Schedule 13D with respect to the Common Stock of Cactus Ventures, Inc., dated as of August 22, 2013, is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(f) under the Securities Exchange Act of 1934.
